Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2024-10-18 00:00:00 ET · period of report 2024-10-16 · accession 0000950170-24-115726 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-10-18 | 2024-10-16 | WVE | Francis Chris | See Remarks | M - OptEx | $2.88 | +129.1K | 22.5K | New | +$371.4K |
| DMT | 2024-10-18 | 2024-10-16 | WVE | Francis Chris | See Remarks | S - Sale+OE | $13.67 | -208.8K | 0 | -100% | -$2.86M |
| DMT | 2024-10-18 | 2024-10-16 | WVE | Francis Chris | See Remarks | M - OptEx | $0.00 | -129.1K | 84.4K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-10-16 | M | A | 40,997 | $2.48 | 40,997 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-10-16 | S | D | 40,997 | $13.00 | 0 | D | — | — | |
| 3 | Common | Ordinary Shares | 2024-10-16 | M | A | 65,625 | $3.14 | 65,625 | D | — | — | |
| 4 | Common | Ordinary Shares | 2024-10-16 | M | A | 22,500 | $2.83 | 22,500 | D | — | — | |
| 5 | Common | Ordinary Shares | 2024-10-16 | S | D | 65,625 | $13.75 | 0 | D | — | — | |
| 6 | Common | Ordinary Shares | 2024-10-16 | S | D | 79,714 | $14.00 | 0 | D | — | — | |
| 7 | Common | Ordinary Shares | 2024-10-16 | S | D | 22,500 | $13.50 | 0 | D | — | — | |
| 8 | Derivative | Share Option (right to buy) | 2024-10-16 | M | D | 40,997 | $0.00 | 0 | D | $2.48 · — to 2025-03-10 | 40,997 Ordinary Shares | (F2) The share options that were exercised in this reportable transaction were fully vested. |
| 9 | Derivative | Share Option (right to buy) | 2024-10-16 | M | D | 22,500 | $0.00 | 22,500 | D | $2.83 · — to 2032-07-25 | 22,500 Ordinary Shares | (F2) The share options that were exercised in this reportable transaction were fully vested. |
| 10 | Derivative | Share Option (right to buy) | 2024-10-16 | M | D | 65,625 | $0.00 | 84,375 | D | $3.14 · — to 2032-01-01 | 65,625 Ordinary Shares | (F3) The share option represented the right to purchase a total of 150,000 ordinary shares, 25% of which became exercisable on January 1, 2023, and the remaining shares vest as to an additional 6.25% quarterly thereafter until January 1, 2026. |